ChartRow logo
INSM
Insmed IncorporatedStock · Health Care · Nasdaq-100 0.2%
$126.31−$5.97 (-4.52%)as of market close, Aug 13, 2026
☾ After hours:$126.33+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

INSM financial statements

The full income statement, balance sheet, and cash-flow statement for Insmed Incorporated (INSM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 171.8M2024-09 178.9M2024-12 181.0M2025-03 182.1M2025-06 211.4M2025-09 213.3M2025-12 215.6M2026-03 216.8M2026-06 218.4M+27.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
606M
YoY+66.7%
364M
YoY+19.2%
305M
YoY+24.4%
245M
YoY+30.2%
188M
YoY+14.6%
Cost of revenue
123M
YoY+43.4%
85.7M
YoY+30.8%
65.6M
YoY+19.0%
55.1M
YoY+24.9%
44.2M
YoY+10.7%
Research & development
771M
YoY+28.9%
598M
YoY+4.8%
571M
YoY+43.6%
398M
YoY+45.7%
273M
YoY+50.6%
Selling, general & administrative
701M
YoY+52.1%
461M
YoY+33.9%
345M
YoY+29.6%
266M
YoY+13.5%
234M
YoY+15.1%
General & administrative
345M
YoY+29.6%
266M
YoY+13.5%
234M
YoY+15.1%
Amortization of intangibles
6.00M
YoY+18.8%
5.05M
YoY+0.0%
5.05M
YoY-0.0%
5.05M
YoY+0.0%
5.05M
YoY+1.0%
Operating income
-1.25B
YoY-42.0%
-878M
YoY-23.8%
-710M
YoY-55.2%
-457M
YoY-21.9%
-375M
YoY-41.4%
Interest expense
83.8M
YoY-1.3%
84.9M
YoY+3.9%
81.7M
YoY+208.9%
26.4M
YoY-34.7%
40.5M
YoY+36.9%
Other non-operating income
-1.84M
YoY-6448.3%
29.0K
YoY-98.4%
1.86M
YoY+131.3%
-5.94M
YoY-78.3%
-3.33M
YoY-922.2%
Pre-tax income
-1.27B
YoY-39.7%
-910M
YoY-21.8%
-747M
YoY-55.6%
-480M
YoY-10.0%
-436M
YoY-49.1%
Income tax
5.03M
YoY+35.6%
3.71M
YoY+45.1%
2.56M
YoY+84.7%
1.38M
YoY+178.7%
-1.76M
YoY-225.4%
-1.28B
YoY-39.7%
-914M
YoY-21.9%
-750M
YoY-55.7%
-482M
YoY-10.8%
-435M
YoY-47.8%
-$6.42
YoY-15.3%
-$5.57
YoY-4.3%
-$5.34
YoY-36.6%
-$3.91
YoY-0.8%
-$3.88
YoY-28.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.79B
YoY+10.6%
1.62B
YoY+74.5%
929M
YoY-27.0%
1.27B
YoY+52.1%
837M
YoY+34.4%
2.26B
YoY+11.8%
2.03B
YoY+52.3%
1.33B
YoY-19.7%
1.66B
YoY+33.2%
1.24B
YoY+56.2%
469M
YoY+57.6%
298M
YoY+31.9%
226M
YoY+18.6%
190M
YoY+40.7%
135M
YoY+13.8%
1.53B
YoY-12.3%
1.74B
YoY+4.7%
1.66B
YoY+5.9%
1.57B
YoY+88.3%
833M
YoY+60.1%
739M
YoY+158.9%
285M
YoY+186.0%
-332M
YoY-477.4%
88.0M
YoY-78.6%
410M
YoY+48.8%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-935M
YoY-36.7%
-684M
YoY-27.5%
-536M
YoY-33.9%
-400M
YoY-10.2%
-363M
YoY-65.6%
-64.6M
YoY+88.9%
-583M
YoY-160.8%
-224M
YoY-546.6%
-34.6M
YoY+46.2%
-64.3M
YoY-842.3%
954M
YoY-28.9%
1.34B
YoY+696.1%
168M
YoY-78.8%
793M
YoY+29.5%
613M
YoY+126.0%
FX effect on cash
931K
YoY+171.2%
-1.31M
YoY-422.8%
-250K
YoY+74.9%
-996K
YoY-6.8%
-933K
YoY-288.9%
Net change in cash
-44.6M
YoY-161.4%
72.7M
YoY+112.3%
-592M
YoY-265.6%
357M
YoY+94.1%
184M
YoY+306.0%
Interest paid
55.4M
YoY+36.4%
40.6M
YoY+13.4%
35.8M
YoY+252.3%
10.2M
YoY-6.7%
10.9M
YoY+18.5%
Income taxes paid
4.14M
YoY+65.7%
2.50M
YoY+27.8%
1.96M
YoY+13.9%
1.72M
YoY+10.2%
1.56M
YoY+91.4%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
37.5B
YoY+200.2%
12.5B
YoY+181.9%
4.43B
YoY+63.8%
2.71B
YoY-16.4%
3.24B
YoY-5.6%
P/S
61.9×
YoY+80.1%
34.4×
YoY+117.6%
15.8×
YoY+41.3%
11.2×
YoY-35.0%
17.2×
YoY-17.6%
P/B
50.8×
YoY+15.9%
43.8×
7.9×
YoY-36.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: INSM's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all INSM filings on SEC EDGAR → Not investment advice.